Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Cell Sci ; 135(6)2022 03 15.
Article in English | MEDLINE | ID: mdl-35274126

ABSTRACT

Liver cancers, including hepatocellular carcinoma (HCC), are the second leading cause of cancer death worldwide, and novel therapeutic strategies are still highly needed. Recently, the endolysosomal cation channel TRPML1 (also known as MCOLN1) has gained focus in cancer research because it represents an interesting novel target. We utilized the recently developed isoform-selective TRPML1 activator ML1-SA1 and the CRISPR/Cas9 system to generate tools for overactivation and loss-of-function studies on TRPML1 in HCC. After verification of our tools, we investigated the role of TRPML1 in HCC by studying proliferation, apoptosis and proteomic alterations. Furthermore, we analyzed mitochondrial function in detail by performing confocal and transmission electron microscopy combined with SeahorseTM and Oroboros® functional analysis. We report that TRPML1 overactivation mediated by a novel, isoform-selective small-molecule activator induces apoptosis by impairing mitochondrial function in a Ca2+-dependent manner. Additionally, TRPML1 loss-of-function deregulates mitochondrial renewal, which leads to proliferation impairment. Thus, our study reveals a novel role for TRPML1 as regulator of mitochondrial function and its modulators as promising molecules for novel therapeutic options in HCC therapy.


Subject(s)
Carcinoma, Hepatocellular , Liver Neoplasms , Transient Receptor Potential Channels , Calcium/metabolism , Carcinoma, Hepatocellular/genetics , Carcinoma, Hepatocellular/metabolism , Humans , Liver Neoplasms/genetics , Liver Neoplasms/metabolism , Lysosomes/metabolism , Mitochondria/metabolism , Proteomics , Transient Receptor Potential Channels/genetics , Transient Receptor Potential Channels/metabolism
2.
Nat Commun ; 13(1): 318, 2022 01 14.
Article in English | MEDLINE | ID: mdl-35031603

ABSTRACT

Lung emphysema and chronic bronchitis are the two most common causes of chronic obstructive pulmonary disease. Excess macrophage elastase MMP-12, which is predominantly secreted from alveolar macrophages, is known to mediate the development of lung injury and emphysema. Here, we discovered the endolysosomal cation channel mucolipin 3 (TRPML3) as a regulator of MMP-12 reuptake from broncho-alveolar fluid, driving in two independently generated Trpml3-/- mouse models enlarged lung injury, which is further exacerbated after elastase or tobacco smoke treatment. Mechanistically, using a Trpml3IRES-Cre/eR26-τGFP reporter mouse model, transcriptomics, and endolysosomal patch-clamp experiments, we show that in the lung TRPML3 is almost exclusively expressed in alveolar macrophages, where its loss leads to defects in early endosomal trafficking and endocytosis of MMP-12. Our findings suggest that TRPML3 represents a key regulator of MMP-12 clearance by alveolar macrophages and may serve as therapeutic target for emphysema and chronic obstructive pulmonary disease.


Subject(s)
Macrophages, Alveolar/enzymology , Matrix Metalloproteinase 12/metabolism , Pancreatic Elastase/metabolism , Pulmonary Emphysema/enzymology , Transient Receptor Potential Channels/deficiency , Animals , Disease Models, Animal , Endosomes/metabolism , Female , Humans , Lung/enzymology , Matrix Metalloproteinase 12/genetics , Mice , Mice, Knockout , Pancreatic Elastase/genetics , Pulmonary Emphysema/genetics , Pulmonary Emphysema/metabolism , Transient Receptor Potential Channels/genetics
3.
ACS Chem Neurosci ; 11(6): 880-887, 2020 03 18.
Article in English | MEDLINE | ID: mdl-32069020

ABSTRACT

While fibrillar deposits of hyperphosphorylated protein tau are a key hallmark of several neurodegenerative diseases such as Alzheimer's disease, small oligomers have been speculated to be the key toxic aggregate species. Trivalent metal ions were shown to promote tau oligomer formation in vitro. However, little is known about potential intercellular spreading mechanisms or toxic modes of action of such oligomers. We investigated interactions of tau monomers and Fe3+/Al3+-induced oligomers with small unilamellar vesicles derived from 1-palmitoyl-2-oleoyl-phosphatidylcholine (neutral, liquid-crystalline phase) and dipalmitoyl-phosphatidylcholine (neutral, gel-phase). We further evaluated the influence of glycogen synthase kinase 3ß (GSK-3ß)-mediated tau phosphorylation applying the single-particle fluorescence spectroscopy techniques fluorescence correlation spectroscopy, fluorescence intensity distribution analysis, and scanning for intensely fluorescent targets. In these experiments, no binding to neutral lipid surfaces was observed for tau monomers. In contrast, metal-ion-induced tau oligomers showed a gain of function in binding to neutral lipid surfaces. Of note, tau phosphorylation by GSK-3ß increased both oligomer formation and membrane affinity of the resulting oligomers. In conclusion, our data imply a pathological gain of function of metal-ion-induced oligomers of hyperphosphorylated tau, enabling membrane binding irrespective of surface charge even at nanomolar protein concentrations.


Subject(s)
Glycogen Synthase Kinase 3 beta , Metals , tau Proteins , Alzheimer Disease/metabolism , Ions , Lipids , Phosphorylation , tau Proteins/metabolism
4.
Elife ; 72018 11 27.
Article in English | MEDLINE | ID: mdl-30479274

ABSTRACT

Cytokines and chemokines are produced and secreted by a broad range of immune cells including macrophages. Remarkably, little is known about how these inflammatory mediators are released from the various immune cells. Here, the endolysosomal cation channel TRPML2 is shown to play a direct role in chemokine trafficking and secretion from murine macrophages. To demonstrate acute and direct involvement of TRPML2 in these processes, the first isoform-selective TRPML2 channel agonist was generated, ML2-SA1. ML2-SA1 was not only found to directly stimulate release of the chemokine CCL2 from macrophages but also to stimulate macrophage migration, thus mimicking CCL2 function. Endogenous TRPML2 is expressed in early/recycling endosomes as demonstrated by endolysosomal patch-clamp experimentation and ML2-SA1 promotes trafficking through early/recycling endosomes, suggesting CCL2 being transported and secreted via this pathway. These data provide a direct link between TRPML2 activation, CCL2 release and stimulation of macrophage migration in the innate immune response.


Subject(s)
Chemokine CCL2/metabolism , Macrophages/metabolism , Transient Receptor Potential Channels/agonists , Animals , Cell Movement/drug effects , Immunologic Factors/metabolism , Macrophages/drug effects , Mice, Inbred C57BL
5.
Sci Pharm ; 82(3): 501-17, 2014.
Article in English | MEDLINE | ID: mdl-25853064

ABSTRACT

Ortho-hydroxy-anilides are part of natural products like the new antibiotics platencin (A) and platensimycin (B). An important step in the total synthesis of these antibiotics or their derivatives is the preparation of the o-hydroxy-anilide partial structure. The presented method allows the preparation of o-hydroxy-anilides and o-dihydroxy-anilides from 2-nitrophenol esters in a one-step synthesis without protecting the hydroxy group. Aryl- and alkyl-anilides were prepared following this method as simple analogues of platensimycin (A). The resulting compounds were tested in an agar diffusion assay for their antibiotic potency.

6.
Arch Pharm (Weinheim) ; 345(8): 657-62, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22549797

ABSTRACT

Since the isolation of the natural products platensimycin and platencin as new antibiotic lead structures, several total syntheses as well as syntheses of derivatives have been developed. Most of these approaches are very laborious and the target molecules are often produced in only poor overall yields. The following approach describes the synthesis of rather simple platensimycin analogues focussing on some structure elements that have previously been identified as being essential for binding to the Fab F enzyme in fatty acid biosynthesis. Two of the new analogues show significant antimicrobial activities.


Subject(s)
Adamantane/chemical synthesis , Adamantane/pharmacology , Aminobenzoates/chemical synthesis , Aminobenzoates/pharmacology , Anilides/chemical synthesis , Anilides/pharmacology , Anti-Infective Agents/chemical synthesis , Anti-Infective Agents/pharmacology , Adamantane/chemistry , Aminobenzoates/chemistry , Anilides/chemistry , Anti-Infective Agents/chemistry , In Vitro Techniques , Microbial Sensitivity Tests/methods , Microbial Sensitivity Tests/statistics & numerical data , Molecular Structure , Structure-Activity Relationship
SELECTION OF CITATIONS
SEARCH DETAIL
...